Endothelial dysfunction in chronic renal failure: Roles of lipoprotein oxidation and pro-inflammatory cytokines

Nephrology Dialysis Transplantation

Volumn 16, Issue 6, 2001, Pages 1189-1197

  Bolton, Colin H ^a   Downs, Leonie G ^a   Victory, Jason G G ^a   Dwight, Jeremy F ^a   Tomson, Charles R V ^a   Mackness, Michael I ^b   Pinkney, Jonathan H ^a  

^a SOUTHMEAD HOSPITAL   (United Kingdom)

^b MANCHESTER ROYAL INFIRMARY   (United Kingdom)

Author keywords

Cytokines; Endothelial function; Ischaemic heart disease; Lipid oxidation; Renal failure; Vasodilatation

Indexed keywords

AUTOANTIBODY; BIOLOGICAL MARKER; C REACTIVE PROTEIN; CELL ADHESION MOLECULE; COPPER ION; CYTOKINE; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; FIBRINOGEN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 6; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1; VON WILLEBRAND FACTOR;

ADULT; ANALYSIS; ANGINA PECTORIS; ARTICLE; BLOOD LEVEL; CELL FUNCTION; CHOLESTEROL BLOOD LEVEL; CHRONIC INFLAMMATION; CHRONIC KIDNEY FAILURE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION FUNCTION; DISEASE SEVERITY; FEMALE; FOREARM BLOOD FLOW; HEMODIALYSIS PATIENT; HUMAN; INFLAMMATION; ISCHEMIC HEART DISEASE; KIDNEY FUNCTION; LIPID OXIDATION; MALE; POPULATION; PRIORITY JOURNAL; RISK; TRIACYLGLYCEROL BLOOD LEVEL; ULTRAVIOLET RADIATION; VASCULAR ENDOTHELIUM; VASODILATATION;

EID: 0034970869     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/16.6.1189     Document Type: Article

References (38)

1. Controlling the epidemic of cardiovascular disease in chronic renal disease: What do we know? what do we need to learn? where do we go from here
2. Comparison of hemostatic factors and serum malondialdehyde as predictive factors for cardiovascular disease in hemodialysis patients
3. Abnormalities of endothelial function in patients with predialysis renal failure
4. Cell biology of atherosclerosis
5. C-reactive protein, a sensitive marker of inflammation predicts future risk of coronary heart disease in initially healthy middle-aged men
6. Cardiovascular disease, fibrinogen and the acute phase response associations with lipids and blood pressure in patients with chronic renal disease
7. Relation of serum cytokine concentrations to cardiovascular risk factors and coronary heart disease
8. Evidence for a role of tumor necrosis factor alpha in disturbances of triglyceride and glucose metabolism predisposing to coronary heart disease
9. Endothelial-leukocyte adhesion molecules
10. Serum levels of soluble adhesion molecules in chronic renal failure and dialysis patients
11. Prediction of creatinine clearance from serum creatinine
12. Self-administration of a questionnaire on chest pain and intermittent claudication
13. Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis
14. Endothelial dysfunction in type 1 diabetes mellitus: Relationship with LDL oxidation and the effects of vitamin E
15. Estimation of the concentration of low density lipoprotein cholesterol in plasma without the use of the preparative ultracentrifuge
16. Improved measurement of low-density lipoprotein susceptibility to copper-induced oxidation: Application of a short procedure for isolating low-density lipoprotein
17. Aspirin protects low density lipoprotein from oxidative modification
18. Measurement of malondialdehyde in plasma by high performance liquid chromatography with fluorimetric detection
19. A method for the measurement of a diene conjugated derivative of linoleic acid, 18: 2(9,11), in serum phospholipid and possible origins
20. Simultaneous determination of retinol, alpha-tocopherol and beta-carotene in serum by isocratic high performance liquid chromatography
21. Antibody against oxidised LDL and progression of carotid atherosclerosis
22. Endothelium-dependent vasodilatation and distensibility of large arteries in chronic haemodialysis patients
23. Endothelium-dependent vasodilatation is impaired in peritoneal dialysis patients
24. Circulating adhesion molecules VCAM-1, ICAM-1 and E-selectin in carotid atherosclerosis and incident coronary heart disease cases; the atherosclerosis risk in communities (ARIC) study
25. Von Willebrand factor and its relevance to cardiovascular disorders
26. Endothelium-dependent dilatation in the systemic arteries of asymptomatic subjects relates to coronary risk factors and their interaction
27. Effect of cholesterol-lowering therapy on coronary endothelial vasomotor function in patients with coronary artery disease
28. Oxidative stress in haemodialysis
29. Autoantibodies against oxidatively modified LDL in uremic patients undergoing dialysis
30. Is oxidised low-density lipoprotein present in vivo
31. Autoantibodies to oxidised low density lipoproteins in IDDM are inversely related to metabolic control and microvascular complications
32. Carbamylation induced alterations in low density lipoprotein metabolism
33. Alterations in nonenzymatic biochemistry in uremia: Origin and significance of 'carbonyl stress' in long-term uremic complications
34. Interleukin-6 predicts hypoalbuminemia, hypocholesterolemia and mortality in hemodialysis patients
35. IL-6 functions as an exocrine hormone in inflammation
36. Fibrinogen and factor VII in the prediction of coronary risk
37. Inflammatory effects of peritoneal dialysis: Evidence of systemic monocyte activation
38. Differential regulation by cytokines of constitutive and stimulated secretion of von Willebrand factor from endothelial cells